- When is a medicine not a medicine
- Newsletters
- Consensus Statement - Unlicensed/Off-Label Medicines
- About the EAASM
- Counterfeit medicines
- Information for patients
- Useful links
- Media centre
- EAASM reports
- Articles
- Video
- News
- May 2011
- February 2010
- March 2010
- April 2010
- May 2010
- June 2010
- July 2010
- August 2010
- October 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- The Counterfeiting Superhighway
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- Contact us
June 2007
Plavix®: Class 1 medicines recall
The MHRA in conjunction with the EMEA, with assistance from Waymade plc, are recalling parallel distributed stock of batches 3103/1 to 3103/20 of clopidogrel tablets 75mg branded as Plavix®, following the discovery of counterfeit tablets in the legitimate supply chain. The counterfeit medicines were repacked into English language cartons. (4 June 2007, www.mhra.gov.uk)
Casodex®: Class 1 medicines recall
The MHRA with assistance from AstraZeneca UK Ltd, are recalling any parallel imported stock of Lot 65520 (and lot variants) of bicalutamide tablets 50mg branded as Casodex®, following the discovery of counterfeit tablets in the legitimate supply chain. The counterfeit medicine was supplied in French livery via parallel importers into the UK supply chain. (1 June 2007, www.mhra.gov.uk)
News
On 8 November 2010, EuroNews will broadcast an 8-minute news item about counterfeit medicines and proposed anti-counterfeiting legislation. Jim Thomson (Chair, EAASM) was interviewed for the piece which will be screened for one week and available online thereafter.
